operative Hystroscopic Surgery.
Conditions
Interventions
Intervention 1: 400 micro gram Vaginal misoprostol
10-12 hours before surgery. Intervention 2: 400 Microgram sublingual 10-12 hours before surgery. Intervention 3: No intervention.
Treatment - Drugs
400 micro gram Vaginal misoprostol
10-12 hours before surgery
400 Microgram sublingual 10-12 hours before surgery.
No intervention
Sponsors
Tehran University of Medical Sciences.
Eligibility
Sex/Gender
Female
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria:menopausal women and perimenopausal women without history of normal vaginal delivery;who are not pregnant at the time of examination; do not have contraindications for prostaglandins(severe asthma, glaucoma, cardiac disease, hypertension or renal failure); do not have severe uterovaginal prolapse; do not have history of cervical surgery or cervical incompetency.Exclusion criteria: history of normal vaginal delivery in perimenopausal women;pregnancy; have contraindications for prostaglandins(severe asthma, glaucoma, cardiac disease, hypertension or renal failure); have severe uterovaginal prolapse;have history of cervical surgery or cervical incompetency.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervical Width. Timepoint: 10-12 hours after intervention. Method of measurement: by surgeon during operation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of Dilatation. Timepoint: 10-12 hours after Intervention. Method of measurement: By surgeon during operation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Mahboobeh Saberi
Hazret Rasool-e- Akram Hospital
Outcome results
None listed